GW & Wade’s Cognizant CTSH Stock Holding History

GW & Wade’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29,862	Closed	-$2.02M	–	388
2022 Q2	$2.02M	Buy	29,862 +26,897	+907%	+$2.06M	0.09%	140
2022 Q1	$266K	Hold	2,965	–	–	0.01%	331
2021 Q4	$263K	Sell	2,965 -1,371	-32%	-$110K	0.01%	339
2021 Q3	$322K	Buy	4,336 +663	+18%	+$48.9K	0.02%	294
2021 Q2	$254K	Buy	3,673 +724	+25%	+$53.9K	0.01%	341
2021 Q1	$230K	Buy	+2,949	New	+$228K	0.01%	326

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GW & Wade's CTSH Position: Q3 2022 in Review

GW & Wade sold out of Cognizant (CTSH) in Q3 2022, closing a stake of 29,862 shares — an estimated $2.02M sold.

GW & Wade first reported a position in CTSH in Q1 2021 and held it in 6 quarters. The position peaked at $2.02M in Q2 2022. 888 funds tracked by Wall St. Rank hold CTSH as of Q3 2022.

GW & Wade reported no remaining Cognizant position as of Q3 2022 after selling out during the quarter.
GW & Wade sold 29,862 Cognizant shares in Q3 2022, an estimated $2.02M.
GW & Wade first reported a position in Cognizant in Q1 2021 and held it in 6 quarters.
GW & Wade's Cognizant position peaked at $2.02M in Q2 2022.
888 funds tracked by Wall St. Rank held Cognizant as of Q3 2022.

Based on GW & Wade's 13F filing for Q3 2022, filed 10 Nov 2022.